One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy (Q35011405)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy (English)

1 reference

Europe PubMed Central

5 August 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hwang-Huei Wang

1

1 reference

Europe PubMed Central

5 August 2017

Jen-Wei Chou

2

1 reference

Europe PubMed Central

5 August 2017

Kuan-Fu Liao

3

1 reference

Europe PubMed Central

5 August 2017

Zong-Yi Lin

4

1 reference

Europe PubMed Central

5 August 2017

Hsueh-Chou Lai

5

1 reference

Europe PubMed Central

5 August 2017

Chang-Hu Hsu

6

1 reference

Europe PubMed Central

5 August 2017

Chih-Bin Chen

7

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

5 August 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

5 August 2017

11

1 reference

Europe PubMed Central

5 August 2017

11

1 reference

Europe PubMed Central

5 August 2017

1680-1684

1 reference

Europe PubMed Central

5 August 2017

Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Pharmacologic properties of proton pump inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

What constitutes failure for Helicobacter pylori eradication therapy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Antibiotic resistance in Helicobacter pylori.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Metronidazole-resistant Helicobacter pylori in an urban Asian population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Antibiotic resistance problems with Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Helicobacter pylori and gastroesophageal reflux disease: friends or foes?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Helicobacter pylori and the pathogenesis of gastroduodenal inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

8 July 2018

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

Seven-day therapy for Helicobacter pylori in the United States

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

One-Day Quadruple Therapy Compared With 7-Day Triple Therapy for Helicobacter pylori Infection

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

Failure of a 1-day high-dose quadruple therapy for cure of Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

Factors associated with treatment failure of Helicobacter pylori infection in a developing country

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

Characteristics of differences in Helicobacter pylori serology and 13C-urea breath-testing in an asymptomatic sample of blood donors

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

25 October 2018

A 3-day anti-Helicobacter pylori therapy is a good alternative for bleeding peptic ulcer patients with Helicobacter pylori infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

25 October 2018

The 13C-urea blood test accurately detects active Helicobacter pylori infection: a United States, multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305953

25 October 2018

An international association between Helicobacter pylori infection and gastric cancer

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I11.1680

21 January 2018

Effectiveness of omeprazole-amoxicillin-clarithromycin (OAC) therapy for Helicobacter pylori infection in a Japanese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current guidelines for the eradication of Helicobacter pylori in peptic ulcer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of Helicobacter pylori in primary gastric MALT lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15786549

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V11.I11.1680

1 reference

Europe PubMed Central

5 August 2017

release_wctqlnteszcehmjsykscbrpzrm

1 reference

https://api.fatcat.wiki/v0/release/wctqlnteszcehmjsykscbrpzrm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35011405&oldid=1843345281"